文章类型/Manuscript Types

研究文章

原创研究稿件应作为研究文章提交。各部分应按以下方式准备：

引言：引言部分应清晰展示研究目的，提供相关研究的简要总结，并展示该研究领域的新进展。

•     结果：结果部分应简洁的、有逻辑的进行陈述，尽量避免加入个人判断。

•     讨论：讨论部分应结合本研究的新发现和已发表的论文发现进行阐述。讨论部分也应声明本研究的局限性。

•     结论：结论应清晰、简洁（少于五句话）。

更多信息请见研究文章示例。

综述文章

综述文章旨在提供一个领域或主题的容易理解的、权威的概述。综述文章的作者应谨记，他们在该领域具有可靠的专业素养。综述文章的写作应按以下方式撰写：

•     综述文章格式灵活，没有长度限制。

•     在适当情形下，应描述参考文献的收集方法。

•     建议使用标题、副标题和段落标题使文章结构更清晰。

•     结论：结论应清晰、简洁（少于五句话）。

更多信息请见综述文章示例。

病例报告

病例报告是对某一疾病的症状、体征、诊断、治疗、随访和结果得出的详细报告。

文章应包括以下四个部分：引言、单一病例或多个相似病例的临床报告、讨论、结论。

更多信息请见病例报告示例。

Research Articles

Manuscript on original studies should be submitted as Research Articles. The sections should be prepared as follows:

•     Introduction: The introduction should clearly show the objective of the study, provide a brief summary of previous relevant studies, and demonstrate the new advances in the current investigation.

•     Materials and Methods: This section should briefly give clear and solid information to allow duplication by an independent observer.

•     Results: The results should be a concise and logical account of the new information discovered, with the least personal judgment.

•     Discussion: The discussion should incorporate the significance of the new information and relevance of the novel findings in light of existing knowledge. Limitations should also be stated.

•     Conclusions: The conclusions should be drawn clearly and concisely (less than five sentences).

More information is available in the Research Article sample.

Review Articles

Review articles aim to provide accessible, authoritative overviews of a field or topic. Potential authors should keep in mind that they are expected to have expertise in the reviewed field. The sections should be arranged as follows:

•     Review articles have a flexible format with no restricted length.

•     If appropriate, the method of reference collection should be described.

•     The use of headings, subheadings, and paragraph titles is recommended to improve clarity.

•     Conclusions: The conclusions should be drawn clearly and concisely (less than five sentences).

More information is available in the Review Article sample.

Case Reports

A case report is a detailed report of the symptoms, signs, diagnosis, treatment, follow-up and outcomes of a certain disease.

The article should include to the following four parts: introduction, case report or clinical series, discussion, conclusions.

More information is available in the Case Report sample.

文章格式/Manuscript Format

请注意，文章必须包含以下部分：

标题页

伦理和知情同意声明

临床试验注册信息

研究亮点

摘要和关键词

正文

致谢

参考文献

图注

单位和缩写

更多详情请见下文。

标题页：标题页应包括文章标题、作者姓名、所属机构、通讯作者的联系信息（完整的邮政地址、电话和传真号码以及电子邮件地址）以及利益冲突声明（须声明作者可能存在的现有和潜在的利益冲突）。

伦理声明：涉及人类参与者、人类样本（组织、血液、体液等）或人类来源数据的研究，必须按照《赫尔辛基宣言》进行，并且必须获得适当伦理委员会的批准。涉及动物实验的研究必须表明是否遵循了某个机构的指南、国家研究机构的指南或任何关于实验动物护理和使用的国家法律。如有必要，必须提供包括伦理委员会的名称和注册编码在内的声明，以及伦理审查委员会（IRB）批准报告或伦理委员会报告。如果一项研究已被免除伦理批准，也应在文章中声明。伦理声明应在标题页的末尾和方法部分被披露。

患者知情同意声明：涉及人类受试者或人类组织的实验研究必须包含一份声明，表明已从患者或监护人那里获得了参与研究的知情同意。另外，请尽可能匿名化患者的详细信息，这是法律要求。对于没有个人信息和非常有限的临床数据的研究，或对于回顾性研究，同时基于伦理审查委员会的意见，可以免除患者的知情同意。然而，对于涉及在世患者的病例报告，不能免除该患者的知情同意。

临床试验注册：临床试验指的是“前瞻性地将人类参与者或人群分配到一个或多个与健康相关的干预措施中，以评估其对健康结果的影响”的任何研究。纯观察性研究不需要注册。请在适当情形下提供临床试验注册的注册名称、试验编号和注册登记网址。临床试验注册信息应在摘要和方法部分公开。强烈建议作者在包括clinicaltrials.gov、欧盟临床试验登记网站（https://www.clinicaltrialsregister.eu/）以及世界卫生组织国际临床试验注册平台（https://www.who.int/clinical-trials-registry-platform）列出的数据库中预先注册临床试验。

研究亮点：研究亮点是研究发现的核心要点。本期刊要求提供研究亮点。文章须列出3-5个要点。

摘要与关键词：摘要应简要说明研究目的、所得结果和主要结论。作者必须在摘要末尾提供3-5个关键词。

正文：研究文章的正文应按照标准形式准备，包括以下部分：引言、材料与方法、结果、讨论和结论。综述文章应根据需要分为不同的部分和小节，无需编号。病例报告应分为引言、病例介绍、结果和结论。

致谢：致谢部分应清楚描述该研究曾接受帮助的情况，包括资金支持（应声明资金来源和项目编号）、知识援助、引用图像来源声明等。

参考文献：期刊参考文献应根据Zentime的EndNote X格式进行排版。

Endnote样式：期刊文章

Author. Title. Journal Year;Volume(Issue):Pages.

e.g., Fan ZZ, Chen ZH, Luitel SD, et al. Advances on ultrasound-guided radial artery catheterization. Perioper Precis Med 2023;1(1):2-14.

Endnote样式：书籍

Author. Title. Place Published. Publisher, Year.

Endnote样式：书籍章节

Author. Chapter Title. In: Editor, editors. Book Title. Place Published. Publisher, Year. p. Pages.

Endnote样式：学生论文

Author. Title. University Year.

Endnote样式：网页

Title. Available at: URL

Endnote样式：提前出版

Author. Title (Advance online publication). Journal Year;Volume(Issue):Pages.

Endnote样式：预印本

Author. Title (Preprint). Platform Year.

Endnote样式：专利

Author. Title. Place applied patent No. Date (2023/06/30).

Endnote样式：会议论文集

Author. Title. Volume (No.): Name of Proceedings. Publisher Year;Pages.

Endnote样式：会议论文

Author. Title. Conference Name Year;Pages.

图注：图注必须包含整个图片的简要标题（加粗）和对每个子图的详细描述。此外，所有用于表示图中显著差异的符号都必须进行相应地定义。

单位和缩写：所有测量都应使用国际单位制（SI）单位。所有缩写应在首次出现时明确定义，除非这些缩写词是国际公认的，并且除非它们在摘要或文本中至少出现3次，否则不应使用缩写。

配图和表格：

所有表格应以可编辑的三线表表格形式提供在Word文件中。按照表格在文本中首次引用的数字顺序连续引用表格，并用阿拉伯数字（表1、表2等）标注，为每个表格提供简短标题以及（如有）注释。

所有配图应以至少300 dpi的首选分辨率业进行制作，格式为JPEG或TIFF。按照配图在文本中首次引用的顺序连续引用图片，并用阿拉伯数字（图1、图2等）标注，为每个配图提供简短标题及图释。子图应在左上角适当标注（图A、图B等），并进行详细描述，尤其是统计符号。

请注意，补充文件中的图表应与表格和配图一起提交，表格和配图文件（WORD、JPEG或TIFF和ZIP）的大小不应超过50Mb。

补充文件

与文章直接相关但非必须的补充材料，应与稿件和其他文件分开，在一个单独的文件中进行提交。

语言编辑证书、伦理审查委员会（IRB）批准报告或伦理委员会报告、补充方法等，可以作为补充文件提交（最大文件：50Mb）。

Please note that articles must contain the following components:

Title Page

Ethics and Consent

Clinical Trials Registration

Highlights

Abstract & Keywords

Main Text

Acknowledgements

References

Figure legends

Units and Abbreviations

Please see below for further details

Title Page: The title page should include a manuscript title, authors’ name, affiliations, corresponding author’s contact information (full postal address, telephone and fax numbers and e-mail address) and conflicts of Interest (existed and potential conflicts of interest that authors may have).

Ethics and consent: Research involving human participants, human samples (tissue, blood, body fluid etc.), or human data, must have been conducted in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. Research involving experiments on animals must demonstrate whether an institution's guide, a national research council's guide, or any national law on the care and use of laboratory animals was followed. A statement including the name of the ethics committee and the reference number, and Institutional Review Board (IRB) Approval Report or Ethics Committee Report must be provided if applicable. If a study has been granted an exemption from requiring ethics approval, this should also be stated in the manuscript. The Ethics and Consent should be disclosed both in the end of Title Page and in the Method part.

Patient consent: Research involving experiments with human subjects or tissues must include a statement declaring that informed consent was obtained from the subjects or guardians for participation in the study. Additionally, please anonymize the patient’s details as much as possible, which is a legal requirement. For studies with no personal information and very limited clinical data, or studies with a retrospective design, consent may be waived based on the opinions of the IRB. However, for case reports involving living patients, consent cannot be waived.

Clinical Trial Registration: Clinical trials refer to "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate their effects on health outcomes". Purely observational studies do not require registration. Please provide the name of the registry of clinical trial, the trial number, and the trial URL when appropriate. The information of Clinical Trial Registration should be disclosed both in the Abstract and Method parts. Authors are strongly encouraged to pre-register clinical trials in suitable databases including clinicaltrials.gov, the EU Clinical Trials Register and those listed by the International Clinical Trials Registry Platform of World Health Organization.

Highlights: Highlights are bullet points that convey the core findings of your study. Highlights are mandatory for this journal. The manuscript may include up to three to five bullet points.

Abstract & Keywords: The abstract should briefly show the aim of the research, the results obtained and the major conclusions. The authors must include 3 to 5 key words or phrases at the end of the abstract.

Main Text: The manuscript body of RESEARCH ARTICLES should be organized in a standard form with the following separate sections: Introduction, Materials and Methods, Results, Discussion and Conclusion. REVIEW ARTICLES should be divided into sections and subsections as appropriate without numbering. Case reports should be organized in Introduction, Case Presentation, Results, and Conclusion.

Acknowledgements: The acknowledgments should clearly describe aids including financial supports (grant source and number should be specified), intellectual assistance, image credits etc.

References: The journal references should be formatted according to the EndNote X Style for Zentime ZENTIME PUBLISHING CORPORATION.zip.

Endnote Style：Journal Article

Author. Title. Journal Year;Volume(Issue):Pages.

e.g., Fan ZZ, Chen ZH, Luitel SD, et al. Advances on ultrasound-guided radial artery catheterization. Perioper Precis Med 2023;1(1):2-14.

Endnote Style：Book 

Author. Title. Place Published. Publisher, Year.

Endnote Style：Book Section/Chapter 

Author. Chapter Title. In: Editor, editors. Book Title. Place Published. Publisher, Year. p. Pages.

Endnote Style：Thesis 

Author. Title. University Year.

Endnote Style：Web page 

Title. Available at: URL

Endnote Style：Advance online publication 

Author. Title (Advance online publication). Journal Year;Volume(Issue):Pages.

Endnote Style：Preprint 

Author. Title (Preprint). Platform Year.

Endnote Style：Patent 

Author. Title. Place applied patent No. Date (2023/06/30).

Endnote Style：Conference Proceedings 

Author. Title. Volume (No.): Name of Proceedings. Publisher Year;Pages.

Endnote Style：Conference Paper 

Author. Title. Conference Name Year;Pages.

Figure legends: Figure legends must contain a brief title (bold) for the whole figure and a detailed description of each panel or part. In addition, all symbols used to indicate significant differences in the figures must be defined accordingly.

Units and Abbreviations: System International (SI) units should be used for all measurements. All abbreviations should be explicitly defined at their first occurrence, except for those internationally acceptable and should not be used unless they appear at least 3 times in the abstract or text.

Tables & Figures

All tables should be provided in the three-line table format (editable) in a Word file. Cite tables consecutively in the numerical order of their first citation in the text by Arabic numbers (Table 1, Table 2, etc.), and provide a brief title as well as notes (if any) for each.

All figures should be professionally prepared at a preferred resolution of at least 300 dpi, in jpeg or tiff format. Cite figures consecutively in the order of their first citation in the text by Arabic numbers (Figure 1, Figure 2, etc.) and provide a brief title as well as figure legends for each. Subfigures should be labeled appropriately (Figure 1A, Figure 1B, etc.) in the top left corner and described in detail, especially the statistical symbols.

Please note that supplementary tables and figures should be submitted together with tables and figures, and the Tables & Figures file (WORD, JPEG OR TIFF, and ZIP) should not exceed 50 Mb in size.

Supplementary File

Supplementary files, which are directly relevant but not essential to the conclusions of the paper, should be submitted in a separate file along with the manuscript and with all subsequent submissions.

Language editing certificate, Institutional Review Board (IRB) Approval Report or Ethics Committee Report, supplementary methods, etc. can be submitted as a supplementary file (Maximum file size: 50 Mb).

出版伦理声明/Publication Ethics Statement

通常，Zentime遵循由包括出版伦理委员会（COPE；https://publicationethics.org/）、世界医学编辑协会（WAME；www.wame.org）和国际医学期刊编辑委员会（ICMJE；www.icmje.org）在内的机构制定的指导原则。

作者伦理指南

作者应遵守学术伦理，并将始终：

a. 文章中的所有材料未在其他地方发表或正考虑发表，除非得到编辑的批准。

b. 所有作者共同设计并进行研究工作，且所有作者均已阅读、同意并批准了稿件的投稿和出版。

c. 稿件中的所有数据都是真实的（未伪造或篡改）且可检索。

d. 提交的稿件中所有的研究工作都是原创的，没有抄袭。引用或复制自其他来源的任何内容都应予以承认并引用（必要时需获取引用许可）。

e. 明确声明任何利益冲突，例如，就业、咨询、个人关系和学术竞争。

f. 涉及人类参与者、人类材料或人类数据的研究，必须按照《赫尔辛基宣言》进行，并且必须得到当地伦理委员会的批准。涉及对人类受试者或组织进行实验的研究必须包含一项声明，声明已从患者或监护人处获得了参与研究或使用其组织的知情同意。涉及动物实验的研究必须证明是否遵循了机构指南、国家伦理委员会指南或任何关于实验动物的护理和使用的国家法律。如有必要，必须提供包括伦理委员会的名称和伦理号以及伦理审查委员会（IRB）批准报告或伦理委员会报告的声明。如果一项研究已被免除伦理批准，也应在稿件中详细说明。

g. 如果发现出版稿件中有重大错误，应立即通知期刊编辑或出版商，并在必要时进行撤稿或勘误。

h. 应推荐三名同行评审专家及并提供其详细的联系信息（如果有的话），他们应是文章相关研究领域的专家，并能够对稿件提供客观评价。

以上说明并不详尽，作者应了解本地法规和学术出版界接受的规范。

审稿人伦理指南

审稿人负责进行专业评审，并将始终：

a. 审核通过具有卓越学术水准的稿件。

b. 客观且及时地评审稿件。

c. 将收到的待审阅稿件视为机密文件；不使用或泄露手稿中包含的信息、论点或解释。

d. 待审阅稿件如果全部或部分地与任何已发布或先前提交的稿件相似，应及时向编辑反馈。

e. 指出未被作者引用的相关已发表论文。

f. 提示可能存在的相关的任何潜在利益冲突。

有关评审稿件的指导，请参阅审稿人指南。此处的细节仅与一些特定的伦理问题相关。

编辑伦理指南

编辑负责整个稿件审阅过程，并将始终：

a. 以平衡、公正和客观的方式行事，不因作者的性取向、宗教或政治信仰、性别、种族或地理背景而有所歧视。编辑对接受或拒稿拥有完全的责任和权力。

b. 确保自身与拒绝/接受的稿件不存在利益冲突。

c. 保护审稿人的匿名性。

d. 根据我们的指导原则，妥善处理投诉，无论是伦理上的还是其他方面的。

e. 根据违规的性质和严重程度，决定是否发布勘误或直接撤稿。

出版商伦理指南

作为具备社会责任感的出版商，Zentime将始终：

a. 确保所有发表的文章符合上述标准和要求。

b. 必要时发布任何勘误、撤稿和/或澄清。

c. 维护学术记录的完整性，遵循高水平的知识和伦理标准。

Generally, Zentime follows guidance produced by bodies that include the Committee on Publication Ethics (COPE; https://publicationethics.org/), the World Association of Medical Editors (WAME; www.wame.org) and the International Committee of Medical Journal Editors (ICMJE; www.icmje.org).

Ethical Guidelines for Authors

Authors should abide by academic ethics and always make sure that

a. None of the materials in the paper have been published or are under consideration for publication elsewhere unless approved by the editors.

b. The work was designed and conducted by all the authors and the manuscript has been written, read, and approved by all the authors.

c. All data in the submitted manuscript are authentic (not fabricated or manipulated) and retrievable.

d. All the work in the submitted manuscript is original with no plagiarism. Acknowledge and cite any content reproduced from other sources (obtain permission if necessary).

e. Any conflicts of interest are clearly declared, e.g., employment, consultancy personal relationships and academic competition.

f. Research involving human participants, human materials, or human data, must have been conducted in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. Research involving experimentation with human subjects or tissues must include a statement declaring that informed consent was obtained from the subjects or guardians for participation in the study or use of their tissue. Research involving experiments on animals must demonstrate whether an institution's guide, a national research council's guide, or any national law on the care and use of laboratory animals was followed. A statement including the name of the ethics committee and the reference number, and the Institutional Review Board (IRB) Approval Report or Ethics Committee Report must be provided if applicable. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript.

g. To notify the journal editor or publisher promptly if a significant error in their publication is identified and make retractions or give erratum if necessary.

h. Three potential peer reviewers with detailed contact information should be provided (if any), who are experts in their field of study and will be able to provide an objective evaluation of the manuscript.

This list is not exhaustive, and authors should be aware of local regulations and accepted norms within academic publishing society.

Ethical Guidelines for Reviewers

Reviewers are responsible for the professional review and will always

a. Accept manuscripts with rigorous standards of academic excellence.
b. Review submitted manuscripts objectively and timely.
c. Treat a manuscript received for review as a confidential document; do not use or disclose information, arguments or interpretations contained in a manuscript under review.
d. Alert the editor of any published or previously submitted content that is substantially similar to that under review.
e. Point out relevant published work that has not been cited by the authors.
f. Notify any potential conflicts of interest that may be concerned.

For general guidance on reviewing a manuscript, see information for the reviewers. The details here are related to some specific ethical issues only.

Ethical Guidelines for Editors

Editors are responsible for the whole review process and will always

a. Act in a balanced, fair and objective way without discrimination concerning sexual orientation, religious or political beliefs, gender, ethnic or geographical background of the authors. Editors have complete responsibility and authority to accept a submitted paper for publication or to reject it.
b. Be assured that there is no conflict of interest with respect to manuscripts they reject/accept.
c. Preserve the anonymity of reviewers.
d. Deal with complaints properly, ethical or otherwise, according to our general guidance.
e. Decide whether to publish an erratum or retract a manuscript directly depending on the nature and severity of the infraction.

Ethical Guidelines for Publisher

Zentime, as a responsibility Publisher, will always
a. Ensure that all articles published meet the standards and requirements listed above.
b. Ensure that any erratum, retraction, and/or clarification are published when necessary.
c. Maintain the integrity of the academic record and follow high intellectual and ethical standards.

版权和许可/Copyright and Licensing

文章符合Creative Commons CC BY 4.0开放获取许可，允许其他人下载文章并在适当引用的情况下共享。这样可以最大化文章的使用和曝光，同时确保作者获得适当的知识产权保护。

如果您有特定条件不允许该项授权，请在提交稿件时向期刊的编辑部说明，我们的编辑将妥善处理。

对于先前发布的内容：

作者有责任获取使用其他人材料的许可。如果配图或表格以前已经发表过，应在提交稿件时之前获得版权许可。

请注意，以下情况需要获取许可：

a. 由其他出版商发表作者自己的作品，且作者未保留版权。

b. 大量摘录其他作品。

c. 已发表过的表格、图片、插图、方案和艺术作品，如果它们未经修改或仅仅略有变动。

d. 作者使用未获得版权的照片。

For all articles published in Zentime journals:

Articles are licensed under an open access Creative Commons CC BY 4.0 license, allowing others to download articles and share them only if they properly credit the authors and the publisher. This allows for maximum use and exposure of the work, while ensuring that the authors receive proper credit.

If you have a specific condition that does not allow this license, please specify this to the Editorial Office of the journal on submission, and our editors will deal with it properly.

For previously published content:

Authors are responsible for obtaining permission to use material owned by others. If a figure or table has been published previously, copyright permission should be obtained before submitting the manuscript.

Please note permission is required for

a. The authors’ own work published by other publishers and for which the authors did not retain copyright.

b. Substantial extracts from other works.

c. Previously published tables, graphs, charts, schemes and artworks if they are unaltered or slightly changed.

d. Photographs which the authors do not hold the copyright.